Europe's vaccine makers fall
Drugmakers Fall as Trump Picks Vaccine Sceptic for US Health Job
(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy Jr., who has previously spread misinformation on vaccines, to lead the Department of Health and Human Services (HHS).
Donald Trump has delivered a blow to the drug makers he claims hampered his 2020 election bid with the appointment of vaccine ...
GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...
Shares of several of the world’s largest vaccine makers fell Friday, the day after Donald Trump announced he had selected ...
Vaccine stocks react to Robert F. Kennedy Jr.'s HHS nomination. FDA and NIH express concerns over his anti-vaccine views amid ...
Quarterly sales of GSK's RSV vaccine dropped more than 70%, following narrower recommendations for who should get the shot.
The print ads featured a prominent display of a person’s back, highlighting where shingles rashes typically emerge.
U.K. drugmaker GSK on Wednesday cut its vaccine sales guidance for the year after what it called lower-than-expected demand.
GSK collaborates closely with Canadian sites — such as hospitals and other health-care centres — to operationalize its trials ...
Deutsche Bank downgraded GSK (GSK) to Hold from Buy with a price target of 1,350 GBp, down from 1,700 GBp. The firm cites President-elect ...
The news has already made financial waves for vaccine makers. Since Politico reported on the potential selection Thursday ...
Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback